Does Imiquimod Histologically Rejuvenate Ultraviolet Radiation–Damaged Skin?
Authors:
- Kathleen SmithKSKathleen Smith
- Sate HamzaSHSate Hamza
- Marguerite GermainMGMarguerite Germain
- Henry SkeltonHSHenry Skelton
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (12) , 1419-1429
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- TA-p63-γ regulates expression of ΔN-p63 in a manner that is sensitive to p53Oncogene, 2005
- The Role of Toll-like Receptors in the Pathogenesis and Treatment of Dermatological DiseaseJournal of Investigative Dermatology, 2005
- Cellular and molecular events leading to the development of skin cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Prevention of UV radiation–induced immunosuppression by IL-12 is dependent on DNA repairJournal of Experimental Medicine, 2005
- Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral InfectionJournal of Biological Chemistry, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJournal of the American Academy of Dermatology, 2004
- Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2Human Molecular Genetics, 2004
- The imidazoquinolines and their place in the therapy of cutaneous diseaseExpert Opinion on Pharmacotherapy, 2003
- Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T LymphocytesMolecular and Cellular Biology, 2002
- DNA oligonucleotide treatment corrects the age‐associated decline in DNA repair capacityThe FASEB Journal, 2002